Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

682 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prolonged combination lipid therapy is associated with reduced carotid intima-media thickness: a case-control study of the 20-year Familial Atherosclerosis Treatment - Observational Study (FATS-OS).
Phan BA, Moore AB, Davis J, Pollan LJ, Neradilek B, Brown BG, Zhao XQ. Phan BA, et al. Among authors: zhao xq. J Clin Lipidol. 2014 Sep-Oct;8(5):489-93. doi: 10.1016/j.jacl.2014.07.004. Epub 2014 Jul 12. J Clin Lipidol. 2014. PMID: 25234561 Free PMC article.
Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS).
Zhao XQ, Krasuski RA, Baer J, Whitney EJ, Neradilek B, Chait A, Marcovina S, Albers JJ, Brown BG. Zhao XQ, et al. Am J Cardiol. 2009 Dec 1;104(11):1457-64. doi: 10.1016/j.amjcard.2009.07.035. Am J Cardiol. 2009. PMID: 19932775 Free PMC article.
Effects of niacin on glucose levels, coronary stenosis progression, and clinical events in subjects with normal baseline glucose levels (<100 mg/dl): a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), HDL-Atherosclerosis Treatment Study (HATS), Armed Forces Regression Study (AFREGS), and Carotid Plaque Composition by MRI during lipid-lowering (CPC) study.
Phan BA, Muñoz L, Shadzi P, Isquith D, Triller M, Brown BG, Zhao XQ. Phan BA, et al. Among authors: zhao xq. Am J Cardiol. 2013 Feb 1;111(3):352-5. doi: 10.1016/j.amjcard.2012.09.034. Epub 2012 Nov 17. Am J Cardiol. 2013. PMID: 23168285 Free PMC article. Clinical Trial.
Mortality reduction in patients treated with long-term intensive lipid therapy: 25-year follow-up of the Familial Atherosclerosis Treatment Study-Observational Study.
Zhao XQ, Phan BA, Davis J, Isquith D, Dowdy AA, Boltz S, Neradilek M, Monick EA, Brockenbrough A, Hus-Frechette EE, Albers JJ, Brown BG. Zhao XQ, et al. J Clin Lipidol. 2016 Sep-Oct;10(5):1091-7. doi: 10.1016/j.jacl.2016.06.013. Epub 2016 Jul 9. J Clin Lipidol. 2016. PMID: 27678425 Free PMC article.
682 results